Literature DB >> 27767918

Marseillevirus in the Pharynx of a Patient with Neurologic Disorders.

Sarah Aherfi, Philippe Colson, Didier Raoult.   

Abstract

Entities:  

Keywords:  Marseillevirus; Megavirales; giant virus; megavirome; neurologic disorders; viruses

Mesh:

Year:  2016        PMID: 27767918      PMCID: PMC5088024          DOI: 10.3201/eid2211.160189

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Marseilleviridae is a recently described family of giant amebal viruses (). Although Marseillevirus, its founding member, and subsequently discovered representatives were isolated primarily from environmental water, marseilleviruses have been recovered from humans (,). Senegalvirus, a close Marseillevirus relative, was serendipitously isolated from a healthy man’s feces (). Metagenomics then unexpectedly identified Marseillevirus-related sequences in blood of healthy donors (), which was confirmed by PCR, fluorescence in situ hybridization, and serologic testing. Further PCR and serologic studies suggested substantial exposure of humans to marseilleviruses (,). During assessment of Marseillevirus serology at Institut Hospitalo-Universitaire (IHU) Méditerranée Infection (Marseille, France), we found serum from an 11-month-old boy with lymphadenitis that exhibited a high Marseillevirus IgG titer; the virus was detected by PCR in serum and by fluorescence in situ hybridization and immunohistochemistry in the lymph node (). Subsequently, the hospital implemented systematic Marseillevirus PCR in cases of gastroenteritis or pharyngitis, which led to detection of Marseillevirus DNA in pharyngeal and blood samples from a 20-year-old man. He had sought treatment in November 2013 for a 2-day febrile gastroenteritis that was treated with amoxicillin and acetaminophen; however, several hours later, his fever reached 40°C, and intense headache and stiff neck led to his hospitalization. No adenopathy was palpable. Laboratory analyses showed elevated C-reactive protein (194 mg/L), elevated bilirubin (44 µmol/L), low platelet count (120 G/L), and elevated polynuclear cell count (9 G/L). Cerebrospinal fluid (CSF) was clear and acellular; the CSF to blood glucose ratio was normal, but the protein level was elevated (0.73 g/L). We tested CSF and feces by culture, PCR, or immunoenzyme assay for common infectious agents of meningitis, encephalitis, and gastroenteritis, including enteroviruses, herpesviruses, Neisseria meningitidis, Streptococcus pneumoniae, caliciviruses, rotavirus, adenoviruses, and Clostridium difficile. All results were negative. Feces were also negative for Marseillevirus DNA. Serologic test results were negative for HIV and cytomegalovirus. However, a pharyngeal sample was positive for Marseillevirus in routine diagnosis using the PCR system ORF152 (); sequencing showed 100% nucleotide identity with the Marseillevirus genome (http://www.mediterranee-infection.com/article.php?laref=495&titre=marseillevirus-pharynx). Retrospective testing of CSF for Marseillevirus DNA yielded negative results. The patient recovered after receiving ciprofloxacin and was discharged after 72 hours. One year later, he exhibited vertigo and a 7-kg weight loss over 4 months, although no additional episode of gastroenteritis or fever had occurred. He reported a slight impairment of cognitive functions (i.e., memory, attention), but clinical examination and cerebral positron emission and computed tomographic scan results were normal. Vertigo was attributed to vestibular deficiency and treated with betahistine. CSF testing still showed an isolated high protein level (0.68 G/L) without hypercellularity but negative results for bacteria and viruses. However, Marseillevirus DNA was detected by 2 PCR systems that target a helicase gene: blood testing using the ORF152 PCR and pharyngeal swab specimen testing using the HelF6R6 PCR system (primers: 5′-GAGGATGTACGGAAGGTC-3′ [forward]; 5′-GTCCTTCACCTGTTCTTCC-3′ [reverse]). Sequence identities were 99% and 100%, respectively, with Marseillevirus (GenBank accession no. KU933837; http://www.mediterranee-infection.com/article.php?laref=495&titre=marseillevirus-pharynx). In addition, Marseillevirus IgG was detected by indirect immunofluorescence assay; serum samples that were negative or positive for Marseillevirus IgG in previous experiments were used as negative and positive controls, respectively (). After 2 months, the patient’s general condition had improved, and neurocognitive and vestibular symptoms resolved. Marseillevirus presence in the case-patient is indisputable, as supported by specific molecular detection and sequencing of 2 sequential pharyngeal swab specimens and of blood, with concurrent IgG positivity (Figure). The presence of the virus in 2 samples collected at a 1-year interval suggests chronic carriage.
Figure

Marseillevirus sequences and serologic analysis for a 20-year-old man in Marseille, France, who initially sought treatment in November 2013 for a 2-day febrile gastroenteritis. A) Alignment of the sequence obtained in November 2014 from the blood of the case-patient with sequences from Marseillevirus and other related viruses. GenBank accession nos.: Marseillevirus, GU071086.1; Melbournevirus, KM275475.1; Fontaine Saint-Charles virus, KF582416.1; Senegalvirus, KF582412.1; Marseillevirus isolate blood donor 127, KF233993.1; Marseillevirus isolate blood donor 45, KF233992.1; Cannes 8 virus, KF261120.1; Tunisvirus, KF483846.1; Insectomime virus, KF527888.1; Port-Miou virus, KT428292.1; Lausannevirus, HQ113105.1. B) Phylogenetic reconstruction based on an amino acid alignment of the translated sequence obtained in November 2014 from a pharyngeal swab specimen from the case-patient (GenBank accession no. KU933837; indicated in bold) and homologous sequences from Marseilleviruses. Sequence from Organic Lake phycodnavirus 1 was used as an outgroup. The evolutionary history was inferred in MEGA6 software (http://www.megasoftware.net/) by the neighbor-joining method. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1,000 replicates) is shown next to the branches. The evolutionary distances were computed by using the Kimura 2-parameter method. The tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. Scale bar indicates nucleotide substitutions per site. C–E) Marseillevirus IgG detection by immunofluorescence in a serum sample from the case-patient. C) Serum sample from the case-patient at dilution 1:50; D) negative control (serum sample from a rabbit not exposed to Marseillevirus) at dilution 1:50; E) positive control (serum sample from a rabbit exposed to Marseillevirus) at dilution 1:50.

Marseillevirus sequences and serologic analysis for a 20-year-old man in Marseille, France, who initially sought treatment in November 2013 for a 2-day febrile gastroenteritis. A) Alignment of the sequence obtained in November 2014 from the blood of the case-patient with sequences from Marseillevirus and other related viruses. GenBank accession nos.: Marseillevirus, GU071086.1; Melbournevirus, KM275475.1; Fontaine Saint-Charles virus, KF582416.1; Senegalvirus, KF582412.1; Marseillevirus isolate blood donor 127, KF233993.1; Marseillevirus isolate blood donor 45, KF233992.1; Cannes 8 virus, KF261120.1; Tunisvirus, KF483846.1; Insectomime virus, KF527888.1; Port-Miou virus, KT428292.1; Lausannevirus, HQ113105.1. B) Phylogenetic reconstruction based on an amino acid alignment of the translated sequence obtained in November 2014 from a pharyngeal swab specimen from the case-patient (GenBank accession no. KU933837; indicated in bold) and homologous sequences from Marseilleviruses. Sequence from Organic Lake phycodnavirus 1 was used as an outgroup. The evolutionary history was inferred in MEGA6 software (http://www.megasoftware.net/) by the neighbor-joining method. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1,000 replicates) is shown next to the branches. The evolutionary distances were computed by using the Kimura 2-parameter method. The tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. Scale bar indicates nucleotide substitutions per site. C–E) Marseillevirus IgG detection by immunofluorescence in a serum sample from the case-patient. C) Serum sample from the case-patient at dilution 1:50; D) negative control (serum sample from a rabbit not exposed to Marseillevirus) at dilution 1:50; E) positive control (serum sample from a rabbit exposed to Marseillevirus) at dilution 1:50. Several reports showed that giant viruses may be common in humans, but association with pathogenicity was documented differently, depending on the viruses. Thus, many serologic, virologic, and clinical findings argued for a causative role of mimiviruses in pneumonia, which was strengthened in 2013 by the culture isolation of mimiviruses from 2 pneumonia patients (,). In addition, Acanthocystis turfacea chlorella virus-1, a phycodnavirus that infects algae, was detected by metagenomics in human oropharyngeal samples, and this association was further confirmed by PCR in 92 samples, with a prevalence of 44% (). Unexpectedly, DNA detection of this virus was associated with a decrease in cognitive performance in these patients; such cognitive disorders were also observed in mice inoculated with this virus. The presence of Marseillevirus in healthy humans was described by high-throughput sequencing and subsequent culture isolation from feces (), then by metagenomics in blood donors’ blood (). Unexpectedly, seroprevalence studies conducted in the general population showed high (up to 13%) positivity rates of Marseillevirus IgG, which suggested a common human exposure (–). Presence of Marseillevirus in a symptomatic human was reported in 2013 in an 11-month-old boy with lymphadenitis and possibly corresponded to a primary infection (). Marseillevirus was then detected in the lymph node of a 30-year-old woman with Hodgkin’s lymphoma (). In the case we describe, Marseillevirus was detected in the human oropharynx in association with cognitive impairment and possible chronic carriage with concurrent persistence of clinical signs. The involvement of Marseillevirus in these symptoms cannot be established here, but these findings warrant further investigation.
  10 in total

1.  Giant Marseillevirus highlights the role of amoebae as a melting pot in emergence of chimeric microorganisms.

Authors:  Mickaël Boyer; Natalya Yutin; Isabelle Pagnier; Lina Barrassi; Ghislain Fournous; Leon Espinosa; Catherine Robert; Saïd Azza; Siyang Sun; Michael G Rossmann; Marie Suzan-Monti; Bernard La Scola; Eugene V Koonin; Didier Raoult
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-09       Impact factor: 11.205

2.  Microbial culturomics: paradigm shift in the human gut microbiome study.

Authors:  J-C Lagier; F Armougom; M Million; P Hugon; I Pagnier; C Robert; F Bittar; G Fournous; G Gimenez; M Maraninchi; J-F Trape; E V Koonin; B La Scola; D Raoult
Journal:  Clin Microbiol Infect       Date:  2012-10-03       Impact factor: 8.067

3.  Chlorovirus ATCV-1 is part of the human oropharyngeal virome and is associated with changes in cognitive functions in humans and mice.

Authors:  Robert H Yolken; Lorraine Jones-Brando; David D Dunigan; Geetha Kannan; Faith Dickerson; Emily Severance; Sarven Sabunciyan; C Conover Talbot; Emese Prandovszky; James R Gurnon; Irina V Agarkova; Flora Leister; Kristin L Gressitt; Ou Chen; Bryan Deuber; Fangrui Ma; Mikhail V Pletnikov; James L Van Etten
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-27       Impact factor: 11.205

4.  Lausannevirus seroprevalence among asymptomatic young adults.

Authors:  Linda Mueller; David Baud; Claire Bertelli; Gilbert Greub
Journal:  Intervirology       Date:  2013-10-17       Impact factor: 1.763

5.  Shan virus: a new mimivirus isolated from the stool of a Tunisian patient with pneumonia.

Authors:  Hanene Saadi; Dorine-Gaelle Ikanga Reteno; Philippe Colson; Sarah Aherfi; Philippe Minodier; Isabelle Pagnier; Didier Raoult; Bernard La Scola
Journal:  Intervirology       Date:  2013-10-17       Impact factor: 1.763

6.  Marseillevirus-like virus recovered from blood donated by asymptomatic humans.

Authors:  Nikolay Popgeorgiev; Mickaël Boyer; Laura Fancello; Sonia Monteil; Catherine Robert; Romain Rivet; Claude Nappez; Said Azza; Jacques Chiaroni; Didier Raoult; Christelle Desnues
Journal:  J Infect Dis       Date:  2013-07-02       Impact factor: 5.226

7.  First isolation of Mimivirus in a patient with pneumonia.

Authors:  Hanene Saadi; Isabelle Pagnier; Philippe Colson; Jouda Kanoun Cherif; Majed Beji; Mondher Boughalmi; Saïd Azza; Nicholas Armstrong; Catherine Robert; Ghislain Fournous; Bernard La Scola; Didier Raoult
Journal:  Clin Infect Dis       Date:  2013-05-24       Impact factor: 9.079

Review 8.  Marseillevirus in lymphoma: a giant in the lymph node.

Authors:  Sarah Aherfi; Philippe Colson; Gilles Audoly; Claude Nappez; Luc Xerri; Audrey Valensi; Matthieu Million; Hubert Lepidi; Regis Costello; Didier Raoult
Journal:  Lancet Infect Dis       Date:  2016-08-05       Impact factor: 25.071

9.  Marseillevirus adenitis in an 11-month-old child.

Authors:  Nikolay Popgeorgiev; Gerard Michel; Hubert Lepidi; Didier Raoult; Christelle Desnues
Journal:  J Clin Microbiol       Date:  2013-10-02       Impact factor: 5.948

10.  Marseillevirus prevalence in multitransfused patients suggests blood transmission.

Authors:  Nikolay Popgeorgiev; Philippe Colson; Isabelle Thuret; Jacques Chiarioni; Pierre Gallian; Didier Raoult; Christelle Desnues
Journal:  J Clin Virol       Date:  2013-10-15       Impact factor: 3.168

  10 in total
  8 in total

1.  The Investigation of Promoter Sequences of Marseilleviruses Highlights a Remarkable Abundance of the AAATATTT Motif in Intergenic Regions.

Authors:  Graziele Pereira Oliveira; Maurício Teixeira Lima; Thalita Souza Arantes; Felipe Lopes Assis; Rodrigo Araújo Lima Rodrigues; Flávio Guimarães da Fonseca; Cláudio Antônio Bonjardim; Erna Geessien Kroon; Philippe Colson; Bernard La Scola; Jônatas Santos Abrahão
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

2.  The structure of a virus-encoded nucleosome.

Authors:  Marco Igor Valencia-Sánchez; Stephen Abini-Agbomson; Miao Wang; Rachel Lee; Nikita Vasilyev; Jenny Zhang; Pablo De Ioannes; Bernard La Scola; Paul Talbert; Steve Henikoff; Evgeny Nudler; Albert Erives; Karim-Jean Armache
Journal:  Nat Struct Mol Biol       Date:  2021-04-29       Impact factor: 15.369

3.  Ubiquitous giants: a plethora of giant viruses found in Brazil and Antarctica.

Authors:  Ana Cláudia Dos S P Andrade; Thalita S Arantes; Rodrigo A L Rodrigues; Talita B Machado; Fábio P Dornas; Melissa F Landell; Cinthia Furst; Luiz G A Borges; Lara A L Dutra; Gabriel Almeida; Giliane de S Trindade; Ivan Bergier; Walter Abrahão; Iara A Borges; Juliana R Cortines; Danilo B de Oliveira; Erna G Kroon; Jônatas S Abrahão
Journal:  Virol J       Date:  2018-01-24       Impact factor: 4.099

4.  Lausannevirus Encodes a Functional Dihydrofolate Reductase Susceptible to Proguanil.

Authors:  L Mueller; P M Hauser; F Gauye; G Greub
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 5.  Discovery and Further Studies on Giant Viruses at the IHU Mediterranee Infection That Modified the Perception of the Virosphere.

Authors:  Clara Rolland; Julien Andreani; Amina Cherif Louazani; Sarah Aherfi; Rania Francis; Rodrigo Rodrigues; Ludmila Santos Silva; Dehia Sahmi; Said Mougari; Nisrine Chelkha; Meriem Bekliz; Lorena Silva; Felipe Assis; Fábio Dornas; Jacques Yaacoub Bou Khalil; Isabelle Pagnier; Christelle Desnues; Anthony Levasseur; Philippe Colson; Jônatas Abrahão; Bernard La Scola
Journal:  Viruses       Date:  2019-03-30       Impact factor: 5.048

Review 6.  Mimivirus: leading the way in the discovery of giant viruses of amoebae.

Authors:  Philippe Colson; Bernard La Scola; Anthony Levasseur; Gustavo Caetano-Anollés; Didier Raoult
Journal:  Nat Rev Microbiol       Date:  2017-02-27       Impact factor: 60.633

Review 7.  Marseilleviruses: An Update in 2021.

Authors:  Dehia Sahmi-Bounsiar; Clara Rolland; Sarah Aherfi; Hadjer Boudjemaa; Anthony Levasseur; Bernard La Scola; Philippe Colson
Journal:  Front Microbiol       Date:  2021-06-02       Impact factor: 5.640

8.  Experimental Inoculation in Rats and Mice by the Giant Marseillevirus Leads to Long-Term Detection of Virus.

Authors:  Sarah Aherfi; Claude Nappez; Hubert Lepidi; Marielle Bedotto; Lina Barassi; Priscilla Jardot; Philippe Colson; Bernard La Scola; Didier Raoult; Fabienne Bregeon
Journal:  Front Microbiol       Date:  2018-03-21       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.